课题基金 / 基金详情

REGULATORY MECHANISM FOR THE FORMATION OF TRIVALENT CROSS-LINK (HHL) OF TYPE I COLLAGENS IN ACQUIRED CONNECTIVE TISSUE DISEASES

REGULATORY MECHANISM FOR THE FORMATION OF TRIVALENT CROSS-LINK (HHL) OF TYPE I COLLAGENS IN ACQUIRED CONNECTIVE TISSUE DISEASES
获得性结缔组织疾病中 I 型胶原三价交联 (HHL) 形成的调节机制
批准号:
10670778
负责人:
ISHIKAWA Osamu
金额:
$0.32万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1998
资助国家:
日本
项目状态:
已结题
起止时间:
1998 至 1999

项目摘要

项目成果

ISHIKAWA Osamu的其他基金

相似基金

相关文献

中文摘要
翻译
获得性纤维硬化性疾病的病因尚不清楚,而这种疾病的特点是细胞外基质如胶原的过度积累。先前的研究表明胶原沉积和病变激活的成纤维细胞产生更多的胶原。然而,胶原质的变化尚未被研究。在这个项目中,我们专注于I型拼贴中的一种成熟类型的三价交联,组氨酸二羟基赖氨酸氨基亮氨酸(HHL),并使用我们最近建立的敏感HPLC系统对HHL进行定量。HHL为I型胶原提供了稳定性和生理特性。与正常个体或病灶周围的正常皮肤相比,系统性硬化症或morphea的硬化皮肤样本中HHL与I型胶原的摩尔比分别显著增加。体内HHL形成的调控机制尚不清楚。我们正在研究阐明控制HHL形成的因素,使用补充l -抗坏血酸2-磷酸的体外三维培养系统。该培养体系可为成纤维细胞提供类似于体内条件的最佳培养条件。初步实验显示,缺氧或低血清浓度不影响赖氨酸氧化酶的活性,赖氨酸氧化酶是介导胶原分子活性位点形成的关键酶。总之,HHL可能通过阻止胶原降解参与了纤维硬化性疾病的发展。
英文摘要
The etiology of acquired fibrosclerotic diseases remains unknown while the disease are characterized by excessive accumulation of extracellular matrices such as collagens. Previuous studies have demonstrated deposition of collagens and lesional activated fibroblasts produce more collagens. The qualitative changes of collagens, however, has not been investigated. In this project, we have focused on a mature type of trivalent cross-links, histidinohydroxylysinonorleucine (HHL), in type I collage and quntified HHL using a sensitive HPLC system that we have recently established. HHL provide type I collagens with stability and physiological properties.The molar ratio of HHL to type I collagen was significantly increased in the sclerotic skin samples from systemic sclerosis or morphea as compared with normal individuals or perilesional normal skin, respectively.The regulatory mechanism for the HHL formation in vivo is quite unknown. We are under investigation to elucidate factors that control the HHL formation using an in vitro three-dimensional culture system supplemented with L-ascorbic acid 2-phosphate. This culture system can provide fibroblasts with an optimal culture condition similar to in vivo condition. Preliminary experiments revealed that hypoxia or low serum concentration did not affect the activity of lysyl oxidase, a key enzyme that mediate the formation of reactive sites in collagen molecules.In conclusion, HHL may be involved in the development of fibrosclerotic diseases possibly by preventing collagens from degradation.
期刊论文(15)
专著(0)
科研奖励(0)
会议论文
Tamura M.,Ishikawa O.: J.Dermatol.Sci.. (in press). (2000)
Tamura M.,Ishikawa O.:J.Dermatol.Sci..(印刷中)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Tamura M, Ishikawa O: "An increase of matretype of skin collagen cross-link, histidinohydroxylysinonorleucine, in the clerotic skin of morphea."J Dermatol Sci. (in press). (2000)
Tamura M、Ishikawa O:“在硬斑病的硬化皮肤中,皮肤胶原蛋白交联的基质型(组氨酸羟赖氨酸正亮氨酸)增加。”J Dermatol Sci。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Sato M, Ishikawa O, Miyachi Y: "Distinct patterns of collagen gene expression are seen in normal and keloid fibroblastsgrown in three-dimensional culture."Br J Dermatol. 138. 938-943 (1998)
Sato M、Ishikawa O、Miyachi Y:“在三维培养中生长的正常成纤维细胞和瘢痕疙瘩成纤维细胞中可以看到胶原蛋白基因表达的不同模式。”Br J Dermatol。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
石川治: "強皮症の特殊病型とその臨床像"日皮会誌. 109. 1834-1835 (1999)
Osamu Ishikawa:“硬皮病的特殊疾病类型及其临床特征”日本皮肤病学会杂志 109。1834-1835(1999)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
15
    The establishment of gadolinium-induced skin fibrosis and calcification mice model.
    • 批准号:
      22591237
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.0万
    • 财政年份:
      2010
    • 负责人:
      ISHIKAWA Osamu
    • 依托单位:
    Mechanism of skin fibrosis by lipid mediators and its clinical trials
    • 批准号:
      18591234
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.17万
    • 财政年份:
      2006
    • 负责人:
      ISHIKAWA Osamu
    • 依托单位:
    Control of Anisotropic Order Parameters of Superfluid 3He
    • 批准号:
      17071009
    • 项目类别:
      Grant-in-Aid for Scientific Research on Priority Areas
    • 资助金额:
      $40.51万
    • 财政年份:
      2005
    • 负责人:
      ISHIKAWA Osamu
    • 依托单位:
    Reconstruction of human autologous skin using three dimensional culture and its clinical application
    • 批准号:
      12670807
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.66万
    • 财政年份:
      2000
    • 负责人:
      ISHIKAWA Osamu
    • 依托单位:
    国内基金
    海外基金
    拟南芥叶绿体蛋白HHL1参与病原菌效应因子AvrRpt2触发的免疫反应的功能研究
    • 批准号:
      --
    • 项目类别:
      面上项目
    • 资助金额:
      54万元
    • 批准年份:
      2022
    • 负责人:
      刘兵
    • 依托单位:
    线性方程组量子求解算法(HHL算法)的精确受控旋转研究
    • 批准号:
      --
    • 项目类别:
      面上项目
    • 资助金额:
      54万元
    • 批准年份:
      2022
    • 负责人:
      崔巍
    • 依托单位:
    槲皮素基于ATGL/CGI58调控人HHL5肝细胞脂滴分解的机制研究及临床干预试验